Dong-A Socio Holdings Co., Ltd. (KRX:000640)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Other	201.46B	136.78B	118.51B	138.81B	97.00B
Other Growth	47.29%	15.42%	-14.63%	43.10%	-0.47%
Elimination of Internal Transactions	-209.23B	-239.81B	-179.21B	-187.78B	-170.74B
Biosimilars and Contract Medicines	58.86B	51.45B	27.87B	20.02B	-
Biosimilars and Contract Medicines Growth	14.42%	84.63%	39.17%	-	-
Over-The-Counter Drugs and Quasi-Drugs	678.69B	631.03B	543.01B	437.37B	414.80B
Over-The-Counter Drugs and Quasi-Drugs Growth	7.55%	16.21%	24.15%	5.44%	3.61%
Distribution	400.43B	355.91B	345.33B	304.85B	275.91B
Distribution Growth	12.51%	3.07%	13.28%	10.49%	10.55%
Holding Company	60.37B	58.38B	54.21B	55.87B	51.83B
Holding Company Growth	3.41%	7.70%	-2.98%	7.79%	-15.45%
Packing Containers	103.06B	104.28B	105.15B	112.79B	114.51B
Packing Containers Growth	-1.17%	-0.83%	-6.78%	-1.50%	-13.13%
Bottled Water	39.59B	33.99B	-	-	-
Bottled Water Growth	16.45%	-	-	-	-
Total	1.33T	1.13T	1.01T	881.94B	783.32B
Total Growth	17.78%	11.54%	15.07%	12.59%	1.77%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	3.91B	1.34B	-	-	-
China Growth	192.71%	-	-	-	-
Other	1.12B	1.51B	-	-	328.76M
Other Growth	-25.92%	-	-	-	-
Japan	3.46B	9.83B	-	-	-
Japan Growth	-64.77%	-	-	-	-
South Korea	1.32T	1.12T	-	-	782.99B
South Korea Growth	18.35%	-	-	-	-
Total	1.33T	1.13T	-	-	783.32B
Total Growth	17.78%	-	-	-	-

Source: S&P Global Market Intelligence.